333 Coney St
46 articles with Siemens Healthineers
Siemens Healthineers announces the Food and Drug Administration (FDA) clearance of the MAGNETOM Free.Max, a new High-V magnetic resonance (MR) scanner.
Genetron Health Announces Strategic Partnership with Siemens Healthineers to Promote Precision Oncology for Lung Cancer
Genetron Holdings Limited, a leading precision oncology platform company in China that specializes in offering molecular profiling tests, early cancer screening products and companion diagnostics development, announced a strategic partnership with Siemens Healthineers at the China Medical Equipment Fair.
Biognosys, a leader in next-generation proteomics solutions for drug discovery and development, announces today that it has established a strategic agreement with Siemens Healthineers, a global medical technology company, through its clinical laboratory in Berkeley, California.
Corindus, A Siemens Healthineers Company and one of the leading developers of precision vascular robotics, announced it has been named to Fast Company’s prestigious annual list of the World’s Most Innovative Companies for 2021, earning the No. 5 spot in the robotics category.
TeamViewer supports medical technology providers digitalizing the healthcare sector - Siemens Healthineers already uses TeamViewer globally
Siemens Healthineers uses the remote connectivity platform TeamViewer to support its imaging and laboratory diagnostic equipment worldwide and keep it operational.
Siemens Healthineers and University of Iowa Health Care Team Up to Advance Care for Iowans Over the Next Decade
Siemens Healthineers and University of Iowa Health Care Establish 10-Year Value Partnership to Expand Access to Imaging Technology, Artificial Intelligence Tools, Research, and Workforce Development Opportunities
Siemens Healthineers and WakeMed Announce Innovative Relationship to Advance Care and Improve Outcomes
Value Partnership builds on the long-standing relationship between Siemens Healthineers and WakeMed Health & Hospitals
Siemens Healthineers Announces Collaboration Agreement for Assay Development With an Initial Focus on Multiple Sclerosis
Siemens Healthineers and Novartis collaboration to develop assays supporting Novartis’ therapeutic pipeline. Initial program to focus on development of serum neurofilament light chain (NfL) immunoassay for patients with Multiple Sclerosis (MS) and other neurological diseases. Global distribution on Siemens Healthineers immunoassay platforms.
Siemens Healthineers Collaboration With CDC Will Define Threshold for Neutralizing Antibody Sufficient to Confer Immunity
The collaboration will standardize SARS-CoV-2 assays by defining concentrations of antibodies to specific viral proteins to confer neutralization that could one day be extrapolated to thresholds considered sufficient to confer immunity. Standardization across manufacturers is also expected to improve patient care by enabling long-term antibody level comparison. TARRYTOWN, N.Y.--( BUSINESS WIRE )-- Siemens Healthineers announced today a
The Food and Drug Administration (FDA) has cleared the SOMATOM On.site, a mobile head computed tomography (CT) scanner from Siemens Healthineers that enables a critically ill patient to receive CT head imaging in the intensive care unit (ICU) while remaining in bed. Performing a CT head examination at
The SARS-CoV-2 IgG Antibody Test offers the first EUA for a semi-quantitative assay to help clinicians assess the level of an individual‘s immune response.
Brings Together Highly Complementary Portfolios to Empower Clinicians and Patients in the Fight Against Cancer
Cancels Upcoming Third Quarter Conference Call in Light of Pending Transaction with Siemens Healthineers
Turner Imaging Systems has entered into a Master Resellers agreement which will add the Smart-C® Mini C-Arm to the Siemens Healthineers portfolio of radiology and imaging products. With this agreement, Siemens Healthineers becomes the premium partner reseller to the hospital market and will focus on delivering the Smart-C to their hospital, IDN, GPO and military customers in the United States. International expansion will al
Glassbeam, Inc., the premier machine data analytics company, announced it has expanded its OEM partner ecosystem to include Siemens Healthineers, a leading medical technology company, in its Strategic Reseller program to amplify the access and penetration of Glassbeam Clinsights™ offerings in the healthcare industry.
Siemens Healthineers Receives FDA Emergency Use Authorization for its SARS-CoV-2 Total Antibody Test that Delivers Superior Clinical Performance
Total antibody test has demonstrated 100 percent sensitivity and 99.8 percent specificity in identifying SARS-CoV-2 antibodies. The test detects the antibodies believed to neutralize the SARS-CoV-2 virus; specifically targeting antibodies that attach to a spike protein on the surface of the virus. The test is available on the company’s high-throughput analyzers that can deliver up to 440 tests/hour 1 and report results in as few as 10 minut
Siemens Healthineers Now Shipping Worldwide Total Antibody Test and Molecular Test Kit for COVID-19 with Expanded Capacity
Siemens Healthineers started shipping its total antibody tests globally, including to the largest analyzer installed base in the U.S. The company has a total of 20,000 systems worldwide and will ramp up its production capacity of more than 50 million antibody tests per month as the pandemic evolves.
Corindus Announces New Clinical Data Showing 20 Percent Reduction in Patient Radiation Exposure with Robotic-assisted Intervention
Clinical evidence shows significant patient radiation reduction with CorPath® GRX Vascular Robotic System
Please check out the biopharma industry coronavirus (COVID-19) stories that are trending for May 5, 2020.
Siemens Healthineers announced the availability of its molecular Fast Track Diagnostics SARS-CoV-2 Assay test kit used to aid in the diagnosis of infection by the SARS-CoV-2 virus that causes the COVID-19 disease.